WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
WST stock results show that West Pharmaceutical Servs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace